Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All colchicine studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchColchicineColchicine (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Hospitalization time 24% Improvement Relative Risk Colchicine  Jalal et al.  LATE TREATMENT  RCT Is late treatment with colchicine beneficial for COVID-19? RCT 80 patients in Iraq (May - June 2021) Shorter hospitalization with colchicine (p=0.009) c19early.org Jalal et al., Indian J. Rheumatology, May 2022 Favors colchicine Favors control

Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, clinical trial

Jalal et al., Indian Journal of Rheumatology, doi:10.4103/injr.injr_264_21, NCT04867226
May 2022  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Colchicine for COVID-19
5th treatment shown to reduce risk in September 2020
 
*, now known with p = 0.00000018 from 53 studies.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
Open label RCT of colchicine showing improved recovery with treatment. Only the abstract is currently available. Colchicine 0.5mg bid for 14 days.
This study is excluded in the after exclusion results of meta analysis: minimal details provided.
hospitalization time, 24.1% lower, relative time 0.76, p = 0.009, treatment 36, control 44.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Jalal et al., 5 May 2022, Randomized Controlled Trial, Iraq, peer-reviewed, 3 authors, study period 8 May, 2021 - 18 June, 2021, trial NCT04867226 (history).
This PaperColchicineAll
{ 'DOI': '10.4103/injr.injr_264_21', 'ISSN': ['0973-3698'], 'URL': 'http://dx.doi.org/10.4103/injr.injr_264_21', 'alternative-id': ['344591'], 'author': [ {'affiliation': [], 'family': 'Jalal', 'given': 'AryanMohamadfatih', 'sequence': 'first'}, {'affiliation': [], 'family': 'Aref', 'given': 'SheelanFaroz', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Albustany', 'given': 'DashtyAbbas', 'sequence': 'additional'}], 'container-title': 'Indian Journal of Rheumatology', 'container-title-short': 'Indian J Rheumatol', 'content-domain': {'crossmark-restriction': False, 'domain': []}, 'created': {'date-parts': [[2022, 5, 3]], 'date-time': '2022-05-03T03:21:24Z', 'timestamp': 1651548084000}, 'deposited': { 'date-parts': [[2022, 5, 3]], 'date-time': '2022-05-03T03:22:20Z', 'timestamp': 1651548140000}, 'indexed': {'date-parts': [[2022, 5, 4]], 'date-time': '2022-05-04T13:15:53Z', 'timestamp': 1651670153419}, 'is-referenced-by-count': 0, 'issue': '0', 'issued': {'date-parts': [[2022]]}, 'journal-issue': {'issue': '0', 'published-print': {'date-parts': [[2022]]}}, 'language': 'en', 'member': '2581', 'original-title': [], 'page': '0', 'prefix': '10.4103', 'published': {'date-parts': [[2022]]}, 'published-print': {'date-parts': [[2022]]}, 'publisher': 'Medknow', 'reference-count': 20, 'references-count': 20, 'relation': {}, 'resource': {'primary': {'URL': 'http://www.indianjrheumatol.com/preprintarticle.asp?id=344591;type=0'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': ['Rheumatology'], 'subtitle': [], 'title': 'Effectiveness of colchicine among patients with COVID-19 infection: A randomized, open-labeled, ' 'clinical trial', 'type': 'journal-article', 'volume': '0'}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit